S&P 500   4,586.15 (+0.81%)
DOW   36,145.27 (+0.25%)
QQQ   391.25 (+1.61%)
AAPL   194.43 (+1.10%)
MSFT   370.93 (+0.58%)
META   327.22 (+3.08%)
GOOGL   137.29 (+5.59%)
AMZN   146.95 (+1.68%)
TSLA   241.23 (+0.78%)
NVDA   464.65 (+2.11%)
NIO   7.50 (-3.23%)
BABA   72.28 (+1.11%)
AMD   128.24 (+9.78%)
T   17.08 (+0.83%)
F   10.86 (+1.59%)
MU   73.96 (+1.13%)
CGC   0.73 (+4.66%)
GE   119.16 (-0.54%)
DIS   92.61 (+1.21%)
AMC   6.88 (+1.33%)
PFE   28.74 (-0.17%)
PYPL   58.66 (-1.46%)
XOM   98.30 (-0.82%)
S&P 500   4,586.15 (+0.81%)
DOW   36,145.27 (+0.25%)
QQQ   391.25 (+1.61%)
AAPL   194.43 (+1.10%)
MSFT   370.93 (+0.58%)
META   327.22 (+3.08%)
GOOGL   137.29 (+5.59%)
AMZN   146.95 (+1.68%)
TSLA   241.23 (+0.78%)
NVDA   464.65 (+2.11%)
NIO   7.50 (-3.23%)
BABA   72.28 (+1.11%)
AMD   128.24 (+9.78%)
T   17.08 (+0.83%)
F   10.86 (+1.59%)
MU   73.96 (+1.13%)
CGC   0.73 (+4.66%)
GE   119.16 (-0.54%)
DIS   92.61 (+1.21%)
AMC   6.88 (+1.33%)
PFE   28.74 (-0.17%)
PYPL   58.66 (-1.46%)
XOM   98.30 (-0.82%)
S&P 500   4,586.15 (+0.81%)
DOW   36,145.27 (+0.25%)
QQQ   391.25 (+1.61%)
AAPL   194.43 (+1.10%)
MSFT   370.93 (+0.58%)
META   327.22 (+3.08%)
GOOGL   137.29 (+5.59%)
AMZN   146.95 (+1.68%)
TSLA   241.23 (+0.78%)
NVDA   464.65 (+2.11%)
NIO   7.50 (-3.23%)
BABA   72.28 (+1.11%)
AMD   128.24 (+9.78%)
T   17.08 (+0.83%)
F   10.86 (+1.59%)
MU   73.96 (+1.13%)
CGC   0.73 (+4.66%)
GE   119.16 (-0.54%)
DIS   92.61 (+1.21%)
AMC   6.88 (+1.33%)
PFE   28.74 (-0.17%)
PYPL   58.66 (-1.46%)
XOM   98.30 (-0.82%)
S&P 500   4,586.15 (+0.81%)
DOW   36,145.27 (+0.25%)
QQQ   391.25 (+1.61%)
AAPL   194.43 (+1.10%)
MSFT   370.93 (+0.58%)
META   327.22 (+3.08%)
GOOGL   137.29 (+5.59%)
AMZN   146.95 (+1.68%)
TSLA   241.23 (+0.78%)
NVDA   464.65 (+2.11%)
NIO   7.50 (-3.23%)
BABA   72.28 (+1.11%)
AMD   128.24 (+9.78%)
T   17.08 (+0.83%)
F   10.86 (+1.59%)
MU   73.96 (+1.13%)
CGC   0.73 (+4.66%)
GE   119.16 (-0.54%)
DIS   92.61 (+1.21%)
AMC   6.88 (+1.33%)
PFE   28.74 (-0.17%)
PYPL   58.66 (-1.46%)
XOM   98.30 (-0.82%)

DaVita (DVA) News Today

$105.55
+1.39 (+1.33%)
(As of 02:27 PM ET)
Compare
Today's Range
$104.27
▼
$105.56
50-Day Range
$73.20
▼
$106.61
52-Week Range
$70.80
▼
$116.97
Volume
388,868 shs
Average Volume
839,346 shs
Market Capitalization
$9.64 billion
P/E Ratio
16.19
Dividend Yield
N/A
Price Target
$102.67
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
finance.yahoo.com logoBD (BDX) Launches Advanced Vascular Access Management System
finance.yahoo.com - December 5 at 3:51 PM
markets.businessinsider.com logoDaVita's 'Move It With Purpose' Event Achieves Record-Breaking Participation to Support Life-Saving Care
markets.businessinsider.com - November 30 at 2:20 PM
marketbeat.com logoDaVita Q3 Earnings Transcript
marketbeat.com - November 28 at 7:01 AM
finance.yahoo.com logoWhy You Should Add DaVita (DVA) Stock to Your Portfolio
finance.yahoo.com - November 22 at 12:43 PM
news.yahoo.com logoDaVita health tour in Bay Area to provide free kidney screenings
news.yahoo.com - November 17 at 8:47 PM
finance.yahoo.com logoIs DaVita Inc.'s (NYSE:DVA) ROE Of 30% Impressive?
finance.yahoo.com - November 13 at 10:27 AM
finance.yahoo.com logoAll You Need to Know About DaVita HealthCare (DVA) Rating Upgrade to Strong Buy
finance.yahoo.com - November 10 at 4:00 PM
finance.yahoo.com logoDoes DaVita HealthCare (DVA) Have the Potential to Rally 33.24% as Wall Street Analysts Expect?
finance.yahoo.com - November 9 at 1:13 PM
finance.yahoo.com logoDaVita Inc. (NYSE:DVA) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 8 at 8:36 PM
finance.yahoo.com logoDaVita (DVA) Q3 Earnings & Revenues Top Estimates, Margins Up
finance.yahoo.com - November 8 at 3:36 PM
reuters.com logoDialysis provider DaVita raises full-year profit outlook, shares rise
reuters.com - November 7 at 10:42 PM
msn.com logoDaVita up ~6% after hours on quarterly results beat, raised profit guidance
msn.com - November 7 at 10:42 PM
finance.yahoo.com logoDaVita (DVA) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 7 at 10:42 PM
markets.businessinsider.com logoDaVita Inc. Q3 Profit Increases, beats estimates
markets.businessinsider.com - November 7 at 5:41 PM
finance.yahoo.com logoDaVita Inc. 3rd Quarter 2023 Results
finance.yahoo.com - November 7 at 5:41 PM
finance.yahoo.com logoDaVita Inc. (DVA) Reports Solid Earnings Growth and Robust Cash Flow in Q3 2023
finance.yahoo.com - November 7 at 5:41 PM
markets.businessinsider.com logoFischbeck’s Sell Rating on DVA amidst Dialysis Rate Update and Market Basket Changes
markets.businessinsider.com - October 31 at 1:01 AM
seekingalpha.com logoDaVita: Simple And Compelling After Sell-Off
seekingalpha.com - October 26 at 9:46 AM
finance.yahoo.com logoIs AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - October 23 at 12:42 PM
finance.yahoo.com logoDaVita's (DVA) Latest Partnership to Improve Kidney Care
finance.yahoo.com - October 23 at 12:42 PM
benzinga.com logoDaVita Unusual Options Activity For October 19
benzinga.com - October 19 at 1:32 PM
finance.yahoo.com logoDaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care
finance.yahoo.com - October 18 at 1:02 PM
finance.yahoo.com logoDaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call
finance.yahoo.com - October 17 at 8:54 PM
finance.yahoo.com logoIs DaVita (DVA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
finance.yahoo.com - October 17 at 3:53 PM
marketbeat.com logo3 Must-Buy Warren Buffett Stocks for Volatile Times (DVA)
marketbeat.com - October 16 at 1:13 PM
finance.yahoo.com logoTeleflex (TFX) Advances Urology Portfolio With New Buyout
finance.yahoo.com - October 13 at 6:47 PM
benzinga.com logoThinking about trading options or stock in Tesla, Adobe, Meta Platforms, First Solar, or Davita?
benzinga.com - October 12 at 2:39 PM
markets.businessinsider.com logoDaVita To Closely Monitor Developments Related To GLP-1s
markets.businessinsider.com - October 12 at 2:39 PM
benzinga.com logoDaVita Unusual Options Activity
benzinga.com - October 12 at 2:39 PM
news.yahoo.com logoOzempic's early success in kidney trial to have 'limited application' - DaVita
news.yahoo.com - October 12 at 9:38 AM
markets.businessinsider.com logoDaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Disease
markets.businessinsider.com - October 12 at 9:38 AM
reuters.com logoDaVita says Ozempic's early success in kidney trial to have 'limited application'
reuters.com - October 12 at 9:38 AM
msn.com logoOzempic's early success in kidney disease trial drags down dialysis stocks
msn.com - October 11 at 11:57 PM
barrons.com logoNovo Nordisk Halts Ozempic Kidney Trial. Why It’s Bad for DaVita Stock.
barrons.com - October 11 at 6:56 PM
investing.com logoDaVita, Fresenius Medical Care, Baxter crushed as Ozempic effective in kidney trial
investing.com - October 11 at 1:55 PM
barrons.com logoDialysis Providers Are the Top Decliners in the S&P 500 Wednesday
barrons.com - October 11 at 1:55 PM
msn.com logoWhat's Going On With Kidney Dialysis Provider Stocks Today?
msn.com - October 11 at 1:55 PM
msn.com logoOzempic Study Shakes Up Market for Kidney and Insulin Treatments
msn.com - October 11 at 1:55 PM
msn.com logoOzempic's early success in kidney disease trial hits dialysis stocks
msn.com - October 11 at 1:55 PM
msn.com logoDaVita stock sell-off over Ozempic study "big overreaction," says UBS
msn.com - October 11 at 1:55 PM
finance.yahoo.com logoDaVita (DVA): A Smart Investment or a Value Trap? An In-Depth Exploration
finance.yahoo.com - October 11 at 1:55 PM
investorplace.com logoOzempic Alert: New Trial Causes DaVita (DVA) Stock to Plunge 20%
investorplace.com - October 11 at 1:02 PM
marketbeat.com logoDaVita (NYSE:DVA) Shares Gap Down After Analyst Downgrade
marketbeat.com - October 11 at 11:35 AM
marketbeat.com logoDaVita (NYSE:DVA) Given New $104.00 Price Target at Truist Financial
marketbeat.com - October 11 at 10:15 AM
msn.com logoDaVita shares drop amid update on Ozempic kidney failure study
msn.com - October 10 at 7:46 PM
finance.yahoo.com logoUnveiling DaVita Inc (DVA)'s Market Leadership: A Deep Dive into Its Financial Growth and ...
finance.yahoo.com - October 10 at 2:46 PM
finance.yahoo.com logoDaVita (NYSE:DVA) sheds 3.3% this week, as yearly returns fall more in line with earnings growth
finance.yahoo.com - October 5 at 5:32 PM
seekingalpha.com logoDaVita: Continued Economic Hurdles, Market Expectations May Be Correct
seekingalpha.com - October 4 at 9:46 PM
finance.yahoo.com logoVeradigm (MDRX) Advances Tie-Up to Enhance Care Delivery
finance.yahoo.com - October 4 at 4:05 PM
marketbeat.com logoDaVita Inc. (NYSE:DVA) Short Interest Update
marketbeat.com - October 3 at 11:39 AM
Get DaVita News Delivered to You Automatically

Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.



DVA Media Mentions By Week

DVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DVA
News Sentiment
▼
1.29

0.50
▲
Average
Medical
News Sentiment

DVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DVA Articles
This Week
▼
2

5
▲
DVA Articles
Average Week

Get DaVita News Delivered to You Automatically

Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:DVA) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -